N (95) | Average HU | p Value | |
---|---|---|---|
Recanalization time, min | 91 | 0.08 | |
0–60 | 38 | 55.3 (7.5) | |
>60 | 53 | 63.7 (33.4) | |
Treatment | 94 | ||
IV tPA | 10 | 73.8 (53.2) | |
IA tPA | 54 | 60.6 (24.5) | |
IV + IA tPA | 22 | 54.4 (9.2) | |
No IA or IV tPA | 8 | 52.9 (5.6) | |
mRS at 90 days | 90 | ||
0 | 12 | 54.8 (5.9) | |
1 | 18 | 60.9 (19.4) | |
2 | 11 | 55.3 (8.4) | |
3 | 13 | 53.2 (8.0) | |
4 | 11 | 55.1 (9.5) | |
5 | 8 | 71.4 (42.1) | |
6 | 17 | 70.5 (47.3) | |
mRS at 90 days categorized as good outcome | 90 | ||
mRS 0–2 | 41 | 57.6 (14.0) | 0.34 |
mRS>2 | 49 | 62.6 (33.3) | |
mRS at 90 days categorized as bad outcome | 90 | 0.12 | |
mRS 5–6 | 25 | 70.8 (44.8) | |
mRS<5 | 65 | 56.3 (12.3) | |
Post TICI flow | 95 | ||
0 | 7 | 79.1 (64.6) | |
1 | 4 | 75.4 (37.7) | |
2A | 12 | 60.3 (30.2) | |
2B | 40 | 55.9 (8.5) | |
3 | 32 | 58.6 (22.6) | |
Post TICI flow categorized as good flow | 95 | 0.22 | |
0–2A | 23 | 68.7 (43.2) | |
2B–3 | 72 | 57.1 (16.3) | |
Clinically significant event | 94 | 0.68 | |
Yes | 2 | 52.4 (5.2) | |
No | 92 | 60.1 (26.1) | |
Procedural complications | 95 | 0.14 | |
Yes | 6 | 54.0 (7.1) | |
No | 89 | 60.3 (26.5) | |
Hemorrhage | 95 | 0.90 | |
Yes | 19 | 59.3 (24.8) | |
No | 76 | 60.1 (26.1) | |
Hyperdense MCA | 95 | 0.997 | |
Yes | 92 | 59.9 (26.1) | |
No | 3 | 60.0 (10.2) |
Data are expressed as mean (SD).
HU, Hounsfield Units; IA, intra-arterial; IV, intravenous; MCA, middle cerebral artery; mRS, modified Rankin Scale; TICI, Thrombolysis In Cerebral Ischemia; tPA, tissue plasminogen activator.